Humabs BioMed SA

Humabs BioMed SA specializes in biotechnology, focusing on the discovery and development of anti-infective immunotherapies. The Company develops treatments for major public health threats and utilizes proprietary technology for antibody discovery. Humabs BioMed SA serves government and not-for-profit health organizations in Europe, Switzerland, and the United States.